Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study)
- PMID: 1580094
Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study)
Abstract
The acute effects of hydroxyethylrutosides on capillary filtration were studied in 12 normal subjects, 25 patients with venous hypertension and 22 diabetics with microangiopathy. The two groups of patients randomly received a single oral dose (500 or 1000 mg) of hydroxyethylrutosides. A single dose of 500 mg was used for normal volunteers. In the following 6 hours capillary filtration was studied with straingauge plethysmography. The decrease in capillary filtration was evident within the first hour and was at its peak between the second and fourth hour. After 6 hours it was still significantly below baseline values in patients. The 1000 mg dose was significantly more effective in both groups of patients. This study confirms the efficacy of hydroxyethylrutosides in decreasing capillary filtration. It suggests that the effect of one dose lasts at least 6 hours and also that the higher dose is more effective.
Similar articles
-
Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.Drugs. 1992 Dec;44(6):1013-32. doi: 10.2165/00003495-199244060-00009. Drugs. 1992. PMID: 1282862 Review.
-
5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.Angiology. 2008 Feb-Mar;59 Suppl 1:14S-20S. doi: 10.1177/0003319707312683. Angiology. 2008. PMID: 18287163 Clinical Trial.
-
O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.Angiology. 2008 Feb-Mar;59 Suppl 1:7S-13S. doi: 10.1177/0003319707312021. Angiology. 2008. PMID: 18287162 Clinical Trial.
-
Acute effects of TTFCA on capillary filtration in severe venous hypertension.Panminerva Med. 1994 Jun;36(2):87-90. Panminerva Med. 1994. PMID: 7831065 Clinical Trial.
-
Microcirculatory dysfunction in chronic venous insufficiency (CVI).Microcirculation. 2000;7(6 Pt 2):S3-12. Microcirculation. 2000. PMID: 11151969 Review.
Cited by
-
Effects of hydroxyethylrutosides on the permeability of microvessels in the frog mesentery.Br J Pharmacol. 1993 Sep;110(1):199-206. doi: 10.1111/j.1476-5381.1993.tb13792.x. Br J Pharmacol. 1993. PMID: 8220880 Free PMC article.
-
Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.Drugs. 1992 Dec;44(6):1013-32. doi: 10.2165/00003495-199244060-00009. Drugs. 1992. PMID: 1282862 Review.
-
Effects of hydroxyethylrutosides on hypoxia-induced activation of human endothelial cells in vitro.Br J Pharmacol. 1996 Jun;118(3):599-604. doi: 10.1111/j.1476-5381.1996.tb15443.x. Br J Pharmacol. 1996. PMID: 8762083 Free PMC article.
-
Uptake and localisation of O-(beta-hydroxyethyl)-rutosides in the venous wall, measured by laser scanning microscopy.Eur J Clin Pharmacol. 1992;43(4):423-6. doi: 10.1007/BF02220620. Eur J Clin Pharmacol. 1992. PMID: 1451724 Clinical Trial.
-
Phlebotonics for venous insufficiency.Cochrane Database Syst Rev. 2020 Nov 3;11(11):CD003229. doi: 10.1002/14651858.CD003229.pub4. Cochrane Database Syst Rev. 2020. PMID: 33141449 Free PMC article.